{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:32:53Z","timestamp":1761597173851},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.vaccine.2009.11.005","type":"journal-article","created":{"date-parts":[[2009,11,25]],"date-time":"2009-11-25T13:08:24Z","timestamp":1259154504000},"page":"1363-1372","source":"Crossref","is-referenced-by-count":19,"title":["Chronic inhibition of cyclooxygenase-2 attenuates antibody responses against vaccinia infection"],"prefix":"10.1016","volume":"28","author":[{"given":"Matthew P.","family":"Bernard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Bancos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth P.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Treanor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Topham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard P.","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2009.11.005_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrmicro1819","article-title":"The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus","volume":"6","author":"Karlsson Hedestam","year":"2008","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.11.005_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3201\/eid1204.051020","article-title":"Prospects for universal influenza virus vaccine","volume":"12","author":"Gerhard","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2009.11.005_bib3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.vaccine.2009.11.005_bib4","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/blood-2007-11-123844","article-title":"The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells","volume":"111","author":"Mamani-Matsuda","year":"2008","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.vaccine.2009.11.005_bib5","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.005_bib6","first-page":"397","article-title":"Smallpox: emergence, global spread, and eradication","volume":"15","author":"Fenner","year":"1993","journal-title":"Hist Philos Life Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2009.11.005_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/mi.6.4.6","article-title":"COX-2 in inflammation and resolution","volume":"6","author":"Rajakariar","year":"2006","journal-title":"Mol Interv"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.005_bib8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1471-4906(01)02154-8","article-title":"Prostaglandins as modulators of immunity","volume":"23","author":"Harris","year":"2002","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.005_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4049\/jimmunol.163.1.111","article-title":"Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors","volume":"163","author":"Iniguez","year":"1999","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.005_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clim.2007.07.013","article-title":"COX-2 expression in B lymphocytes: links to vaccines, inflammation and malignancy","volume":"125","author":"Mongini","year":"2007","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.005_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.clim.2007.07.006","article-title":"CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production","volume":"125","author":"Bernard","year":"2007","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.11.005_bib12","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.4049\/jimmunol.174.5.2619","article-title":"Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody production","volume":"174","author":"Ryan","year":"2005","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.11.005_bib13","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.4049\/jimmunol.177.11.7811","article-title":"Cyclooxygenase-2 inhibition attenuates antibody responses against human papillomavirus-like particles","volume":"177","author":"Ryan","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.11.005_bib14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.0105-2896.2006.00392.x","article-title":"Immunity and immunological memory following smallpox vaccination","volume":"211","author":"Amanna","year":"2006","journal-title":"Immunol Rev"},{"issue":"7","key":"10.1016\/j.vaccine.2009.11.005_bib15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.vaccine.2009.11.005_bib16","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.4049\/jimmunol.172.10.6265","article-title":"Cellular and humoral immunity against vaccinia virus infection of mice","volume":"172","author":"Xu","year":"2004","journal-title":"J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.11.005_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jim.2003.12.015","article-title":"Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system","volume":"286","author":"Crotty","year":"2004","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.005_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1084\/jem.165.1.64","article-title":"IgG2a restriction of murine antibodies elicited by viral infections","volume":"165","author":"Coutelier","year":"1987","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.vaccine.2009.11.005_bib19","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.4049\/jimmunol.177.8.5414","article-title":"Induced expression of murine gamma2a by CD40 ligation independently of IFN-gamma","volume":"177","author":"Collins","year":"2006","journal-title":"J Immunol"},{"issue":"5447","key":"10.1016\/j.vaccine.2009.11.005_bib20","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1126\/science.286.5447.2156","article-title":"Control of early viral and bacterial distribution and disease by natural antibodies","volume":"286","author":"Ochsenbein","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2009.11.005_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev.immunol.23.021704.115732","article-title":"Antigen-specific memory B cell development","volume":"23","author":"McHeyzer-Williams","year":"2005","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.11.005_bib22","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1002\/art.23054","article-title":"Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus","volume":"56","author":"Zhang","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.005_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0162-3109(99)00159-9","article-title":"Selective cyclooxygenase-2 (COX-2) inhibitors reduce anti-Mycobacterium antibodies in adjuvant arthritic rats","volume":"46","author":"Turull","year":"2000","journal-title":"Immunopharmacology"},{"issue":"12","key":"10.1016\/j.vaccine.2009.11.005_bib24","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/1529-0131(200012)43:12<2687::AID-ANR8>3.0.CO;2-9","article-title":"The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis","volume":"43","author":"Myers","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.005_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00262-007-0374-4","article-title":"Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cells","volume":"57","author":"Ryan","year":"2008","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.005_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bcp.2007.08.029","article-title":"Celecoxib transiently inhibits cellular protein synthesis","volume":"75","author":"Pyrko","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.11.005_bib27","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djj206","article-title":"Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors","volume":"98","author":"Grosch","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"10.1016\/j.vaccine.2009.11.005_bib28","doi-asserted-by":"crossref","first-page":"7520","DOI":"10.1158\/0008-5472.CAN-08-1060","article-title":"Prevention of both direct and cross-priming of antitumor CD8+ T-cell responses following overproduction of prostaglandin E2 by tumor cells in vivo","volume":"68","author":"Ahmadi","year":"2008","journal-title":"Cancer Res"},{"issue":"20","key":"10.1016\/j.vaccine.2009.11.005_bib29","doi-asserted-by":"crossref","first-page":"9473","DOI":"10.1158\/0008-5472.CAN-05-1659","article-title":"Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors","volume":"65","author":"Ferrario","year":"2005","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.vaccine.2009.11.005_bib30","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1074\/jbc.275.9.6628","article-title":"Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA","volume":"275","author":"Sheng","year":"2000","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.vaccine.2009.11.005_bib31","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.140.4.1022","article-title":"IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses","volume":"140","author":"Finkelman","year":"1988","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.005_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0008-8749(91)90257-C","article-title":"IFN-gamma enhances secretion of IgG2a from IgG2a-committed LPS-stimulated murine B cells: implications for the role of IFN-gamma in class switching","volume":"135","author":"Bossie","year":"1991","journal-title":"Cell Immunol"},{"issue":"13","key":"10.1016\/j.vaccine.2009.11.005_bib33","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1128\/JVI.00115-06","article-title":"Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function","volume":"80","author":"Panchanathan","year":"2006","journal-title":"J Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2009.11.005_bib34","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.005_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10875-006-8787-y","article-title":"COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis","volume":"26","author":"Muthian","year":"2006","journal-title":"J Clin Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.11.005_bib36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2007.03.012","article-title":"COX-2 inhibitors ameliorate experimental autoimmune encephalomyelitis through modulating IFN-gamma and IL-10 production by inhibiting T-bet expression","volume":"186","author":"Ni","year":"2007","journal-title":"J Neuroimmunol"},{"issue":"7","key":"10.1016\/j.vaccine.2009.11.005_bib37","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1128\/JVI.76.7.3329-3337.2002","article-title":"Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope","volume":"76","author":"Harrington","year":"2002","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.005_bib38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-2478(02)00185-2","article-title":"Prostaglandin E2 and cAMP promote B lymphocyte class switching to IgG1","volume":"84","author":"Roper","year":"2002","journal-title":"Immunol Lett"},{"issue":"6","key":"10.1016\/j.vaccine.2009.11.005_bib39","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.1968","article-title":"Prostaglandin E2-EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion","volume":"15","author":"Yao","year":"2009","journal-title":"Nat Med"},{"issue":"9636","key":"10.1016\/j.vaccine.2009.11.005_bib40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(08)61160-5","article-title":"Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case\u2013control study","volume":"372","author":"Jackson","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2009.11.005_bib41","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1586\/14760584.7.4.467","article-title":"Age-related decline in immunity: implications for vaccine responsiveness","volume":"7","author":"Kumar","year":"2008","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09017538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09017538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T17:28:05Z","timestamp":1685208485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09017538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0264410X09017538"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.11.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}